Logo image of HEPS

D-MARKET ELECTRONIC SERV-ADR (HEPS) Stock Fundamental Analysis

NASDAQ:HEPS - Nasdaq - US23292B1044 - ADR - Currency: USD

2.57  +0.01 (+0.39%)

Fundamental Rating

3

HEPS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 31 industry peers in the Broadline Retail industry. HEPS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, HEPS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HEPS has reported negative net income.
In the past year HEPS had a positive cash flow from operations.
HEPS had negative earnings in 4 of the past 5 years.
Of the past 5 years HEPS 4 years had a positive operating cash flow.
HEPS Yearly Net Income VS EBIT VS OCF VS FCFHEPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2B -2B 4B

1.2 Ratios

HEPS's Return On Assets of -6.54% is on the low side compared to the rest of the industry. HEPS is outperformed by 61.29% of its industry peers.
Looking at the Return On Equity, with a value of -43.66%, HEPS is doing worse than 67.74% of the companies in the same industry.
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROIC N/A
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HEPS Yearly ROA, ROE, ROICHEPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 -50

1.3 Margins

HEPS's Gross Margin of 35.27% is on the low side compared to the rest of the industry. HEPS is outperformed by 64.52% of its industry peers.
HEPS's Gross Margin has improved in the last couple of years.
HEPS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%
HEPS Yearly Profit, Operating, Gross MarginsHEPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 30

More info and screens

5

2. Health

2.1 Basic Checks

HEPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HEPS has more shares outstanding
The number of shares outstanding for HEPS has been reduced compared to 5 years ago.
The debt/assets ratio for HEPS has been reduced compared to a year ago.
HEPS Yearly Shares OutstandingHEPS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 100M 200M 300M
HEPS Yearly Total Debt VS Total AssetsHEPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

HEPS has an Altman-Z score of 2.54. This is not the best score and indicates that HEPS is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.54, HEPS is doing good in the industry, outperforming 64.52% of the companies in the same industry.
The Debt to FCF ratio of HEPS is 0.35, which is an excellent value as it means it would take HEPS, only 0.35 years of fcf income to pay off all of its debts.
HEPS's Debt to FCF ratio of 0.35 is amongst the best of the industry. HEPS outperforms 93.55% of its industry peers.
HEPS has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
HEPS has a Debt to Equity ratio (0.44) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Altman-Z 2.54
ROIC/WACCN/A
WACC30.5%
HEPS Yearly LT Debt VS Equity VS FCFHEPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.02 indicates that HEPS should not have too much problems paying its short term obligations.
The Current ratio of HEPS (1.02) is worse than 90.32% of its industry peers.
HEPS has a Quick Ratio of 1.02. This is a bad value and indicates that HEPS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.66, HEPS is doing worse than 80.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.66
HEPS Yearly Current Assets VS Current LiabilitesHEPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5B 10B 15B

More info and screens

6

3. Growth

3.1 Past

HEPS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -573.59%.
HEPS shows a strong growth in Revenue. In the last year, the Revenue has grown by 149.58%.
HEPS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 78.63% yearly.
EPS 1Y (TTM)-573.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.71%
Revenue 1Y (TTM)149.58%
Revenue growth 3Y77.34%
Revenue growth 5Y78.63%
Sales Q2Q%57.93%

3.2 Future

HEPS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.11% yearly.
HEPS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 44.58% yearly.
EPS Next Y-134.57%
EPS Next 2Y3.17%
EPS Next 3Y19.11%
EPS Next 5YN/A
Revenue Next Year75.07%
Revenue Next 2Y55.2%
Revenue Next 3Y44.58%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HEPS Yearly Revenue VS EstimatesHEPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 20B 40B 60B 80B
HEPS Yearly EPS VS EstimatesHEPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

HEPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 32.01, the valuation of HEPS can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as HEPS.
HEPS is valuated expensively when we compare the Price/Forward Earnings ratio to 20.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 32.01
HEPS Price Earnings VS Forward Price EarningsHEPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

HEPS's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, HEPS is valued cheaper than 90.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.56
EV/EBITDA 17.83
HEPS Per share dataHEPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

HEPS's earnings are expected to grow with 19.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.17%
EPS Next 3Y19.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HEPS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

D-MARKET ELECTRONIC SERV-ADR

NASDAQ:HEPS (5/1/2025, 9:07:00 PM)

2.57

+0.01 (+0.39%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)12-10 2024-12-10/bmo
Earnings (Next)N/A N/A
Inst Owners14.19%
Inst Owner Change0.13%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap837.82M
Analysts82.22
Price Target4.23 (64.59%)
Short Float %2.72%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)6.41%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-114.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 32.01
P/S 0.51
P/FCF 6.56
P/OCF 4.86
P/B 8.79
P/tB 35.2
EV/EBITDA 17.83
EPS(TTM)-0.13
EYN/A
EPS(NY)0.08
Fwd EY3.12%
FCF(TTM)0.39
FCFY15.24%
OCF(TTM)0.53
OCFY20.59%
SpS5.01
BVpS0.29
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.27%
FCFM 7.82%
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%
F-Score4
Asset Turnover2.57
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Debt/EBITDA 1
Cap/Depr 94.74%
Cap/Sales 2.74%
Interest Coverage N/A
Cash Conversion 413.77%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.66
Altman-Z 2.54
F-Score4
WACC30.5%
ROIC/WACCN/A
Cap/Depr(3y)121.47%
Cap/Depr(5y)110.53%
Cap/Sales(3y)3.7%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-573.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.71%
EPS Next Y-134.57%
EPS Next 2Y3.17%
EPS Next 3Y19.11%
EPS Next 5YN/A
Revenue 1Y (TTM)149.58%
Revenue growth 3Y77.34%
Revenue growth 5Y78.63%
Sales Q2Q%57.93%
Revenue Next Year75.07%
Revenue Next 2Y55.2%
Revenue Next 3Y44.58%
Revenue Next 5YN/A
EBIT growth 1Y79.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year252.1%
EBIT Next 3Y95.44%
EBIT Next 5YN/A
FCF growth 1Y411.4%
FCF growth 3Y124.57%
FCF growth 5Y100.63%
OCF growth 1Y855.4%
OCF growth 3Y124.87%
OCF growth 5Y97.22%